Zacks Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-31,370	Closed	-$945K	–	517
2017 Q4	$945K	Buy	31,370 +13,794	+78%	+$416K	0.02%	413
2017 Q3	$662K	Buy	+17,576	New	+$662K	0.02%	436